# Ambarella Inc: overview

AMBA · Nasdaq · CIK 1280263 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/amba.md) · [Financials](/companies/amba/financials.md) · [Filings](/companies/amba/filings.md) · [Insiders](/companies/amba/insiders.md)

Latest reported revenue: [$108.1m](/filings/0001193125-26-383365.md) for Q2 FY2027, three months to 2026-07-31, from the 10-Q filed Sep 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-383365).

## Last eight quarters

| Line item | Unit | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [82.7](/filings/0001193125-25-307917.md) | [84.0 d](/filings/0001193125-26-119321.md) | [85.9](/filings/0001193125-26-253198.md) | [95.5](/filings/0001193125-26-383365.md) | [108](/filings/0001193125-25-307917.md) | [101 d](/filings/0001193125-26-119321.md) | [100](/filings/0001193125-26-253198.md) | [108](/filings/0001193125-26-383365.md) |
| Gross margin | % | [60.6%](/filings/0001193125-25-307917.md) | [60.0% d](/filings/0001193125-26-119321.md) | [60.0%](/filings/0001193125-26-253198.md) | [58.9%](/filings/0001193125-26-383365.md) | [59.6%](/filings/0001193125-25-307917.md) | [58.4% d](/filings/0001193125-26-119321.md) | [58.4%](/filings/0001193125-26-253198.md) | [57.7%](/filings/0001193125-26-383365.md) |
| Operating margin | % | [(30.9%)](/filings/0001193125-25-307917.md) | [(30.2%) d](/filings/0001193125-26-119321.md) | [(30.1%)](/filings/0001193125-26-253198.md) | [(23.0%)](/filings/0001193125-26-383365.md) | [(15.0%)](/filings/0001193125-25-307917.md) | [(18.3%) d](/filings/0001193125-26-119321.md) | [(19.3%)](/filings/0001193125-26-253198.md) | [(7.5%)](/filings/0001193125-26-383365.md) |
| Net margin | % | [(29.1%)](/filings/0001193125-25-307917.md) | [(24.1%) d](/filings/0001193125-26-119321.md) | [(28.3%)](/filings/0001193125-26-383365.md) | [(20.9%)](/filings/0001193125-26-383365.md) | [(13.9%)](/filings/0001193125-25-307917.md) | [(16.3%) d](/filings/0001193125-26-119321.md) | [(18.0%)](/filings/0001193125-26-383365.md) | [(6.2%)](/filings/0001193125-26-383365.md) |
| Diluted EPS | $ per share | [(0.58)](/filings/0001193125-25-307917.md) | not reported | [(0.58)](/filings/0001193125-26-253198.md) | [(0.47)](/filings/0001193125-26-383365.md) | [(0.35)](/filings/0001193125-25-307917.md) | not reported | [(0.41)](/filings/0001193125-26-253198.md) | [(0.15)](/filings/0001193125-26-383365.md) |
| Free cash flow | $m | [4.1 d](/filings/0001193125-25-307917.md) | [21.2 d](/filings/0001193125-26-119321.md) | [10.2](/filings/0001193125-26-253198.md) | [1.4 d](/filings/0001193125-26-383365.md) | [31.4 d](/filings/0001193125-25-307917.md) | [15.0 d](/filings/0001193125-26-119321.md) | [(29.6)](/filings/0001193125-26-253198.md) | [(7.1) d](/filings/0001193125-26-383365.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-01-31) | FY2023 (2023-01-31) | FY2024 (2024-01-31) | FY2025 (2025-01-31) | FY2026 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [332](/filings/0000950170-24-038555.md) | [338](/filings/0000950170-25-046499.md) | [226](/filings/0001193125-26-119321.md) | [285](/filings/0001193125-26-119321.md) | [391](/filings/0001193125-26-119321.md) |
| Gross margin | % | [62.7%](/filings/0000950170-24-038555.md) | [61.9%](/filings/0000950170-25-046499.md) | [60.4%](/filings/0001193125-26-119321.md) | [60.5%](/filings/0001193125-26-119321.md) | [59.2%](/filings/0001193125-26-119321.md) |
| Operating margin | % | [(8.9%)](/filings/0000950170-24-038555.md) | [(22.0%)](/filings/0000950170-25-046499.md) | [(68.2%)](/filings/0001193125-26-119321.md) | [(44.4%)](/filings/0001193125-26-119321.md) | [(21.1%)](/filings/0001193125-26-119321.md) |
| Net margin | % | [(8.0%)](/filings/0000950170-24-038555.md) | [(19.4%)](/filings/0000950170-25-046499.md) | [(74.8%)](/filings/0001193125-26-119321.md) | [(41.1%)](/filings/0001193125-26-119321.md) | [(19.4%)](/filings/0001193125-26-119321.md) |
| Diluted EPS | $ per share | [(0.72)](/filings/0000950170-24-038555.md) | [(1.70)](/filings/0000950170-25-046499.md) | [(4.25)](/filings/0001193125-26-119321.md) | [(2.84)](/filings/0001193125-26-119321.md) | [(1.78)](/filings/0001193125-26-119321.md) |
| Free cash flow | $m | [29.1](/filings/0000950170-24-038555.md) | [29.0](/filings/0000950170-25-046499.md) | [7.0](/filings/0001193125-26-119321.md) | [23.5](/filings/0001193125-26-119321.md) | [58.0](/filings/0001193125-26-119321.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/amba/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $47.95 | $4.8k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $48.00 | $4.8k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $48.44 | $4.8k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $47.95 | $4.8k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $47.85 | $4.8k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $47.09 | $4.7k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $48.54 | $4.9k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $48.98 | $4.9k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $48.57 | $4.9k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 200 | $47.95 | $9.6k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $48.71 | $4.9k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $47.77 | $4.8k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $47.25 | $4.7k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $48.88 | $4.9k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $48.60 | $4.9k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $47.83 | $4.8k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $47.10 | $4.7k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $48.47 | $4.8k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 300 | $47.95 | $14.4k | [Form 4](/filings/0001209191-20-023891.md) |
| 2020-03-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | 10% owner | Sale (S) | 100 | $46.83 | $4.7k | [Form 4](/filings/0001209191-20-023891.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

None of the funds in coverage reports a position in its latest 13F.

## Recent filings

[All 1,470 filings](/companies/amba/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-04 | 13:45 ET | [10-Q](/filings/0001193125-26-383365.md) | Quarterly report, period 2026-07-31 | 0001193125-26-383365 |
| 2026-09-03 | 16:19 ET | [8-K](/filings/0001193125-26-381923.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-381923 |
| 2026-07-01 | 17:16 ET | [8-K](/filings/0001193125-26-292824.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-292824 |
| 2026-06-02 | 14:40 ET | [10-Q](/filings/0001193125-26-253198.md) | Quarterly report, period 2026-04-30 | 0001193125-26-253198 |
| 2026-05-28 | 16:10 ET | [8-K](/filings/0001193125-26-245234.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-245234 |
| 2026-05-15 | 17:07 ET | [DEF 14A](/filings/0001193125-26-227183.md) | Proxy statement, period 2026-06-26 | 0001193125-26-227183 |
| 2026-03-23 | 14:15 ET | [10-K](/filings/0001193125-26-119321.md) | Annual report, period 2026-01-31 | 0001193125-26-119321 |
| 2026-02-27 | 17:13 ET | [8-K](/filings/0001193125-26-083175.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-083175 |
| 2026-02-26 | 16:24 ET | [8-K](/filings/0001193125-26-076823.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-076823 |
| 2025-12-04 | 14:30 ET | [10-Q](/filings/0001193125-25-307917.md) | Quarterly report, period 2025-10-31 | 0001193125-25-307917 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0001193125-26-119321.md), filed Mar 23, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1280263
- Tickers: AMBA
- Exchange: Nasdaq
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:39 ET. No prices; not investment advice.